Welcome to Francis Academic Press

International Journal of Frontiers in Medicine, 2021, 3(2); doi: 10.25236/IJFM.2021.030202.

Effect of Mifepristone in the Treatment of Uterine Leiomyoma

Author(s)

Diancui Zhang1, Peipei Sun2, Tongzhen Zhao2

Corresponding Author:
Tongzhen Zhao
Affiliation(s)

1Health Management Center, Binzhou Municipal Hospital of Traditional Chinese Medicine, Binzhou, Shandong Province, 256600,China

2Department of Oncology, Binzhou Municipal Hospital of Traditional Chinese Medicine, Binzhou, Shandong Province, 256600,China

Abstract

To study the effect of mifepristone in the treatment of uterine leiomyoma. Methods :80 cases of uterine leiomyoma treated in our hospital from August 2019 to August 2020, All patients were treated with mifepristone, It was divided into two groups by random number table, Study group A given low dose (12.50 mg/d), Study group B high dose (25.00 mg/d), The changes of serum hormone levels (follicle stimulating hormone (FSH), luteinizing hormone (LH), progestin (P), estrogen (E2)) and uterine leiomyoma volume were compared between the two groups, The adverse reactions of the two groups were compared. Results: Before treatment, Comparison of FSH、LH、P、E2 level and uterine leiomyoma volume between the two groups, and the difference was not statistically significant (P>0.05). After three months of continuous treatment, FSH、LH、P、E2 level, uterine leiomyoma volume was lower than before treatment, The FSH、LH、P、E2 level of the A group was lower than that of the B group, difference was statistically significant (P<0.05); After three months of continuous treatment, The volume of hysteromyoma in the A group compared with the B group, (b) The difference was not statistically significant (P>0.05); The incidence of adverse reactions in the A group was lower than that in the B group, difference was statistically significant (P<0.05). Conclusion: Patients with uterine leiomyoma are treated with drugs, Low-dose mifepristone can reduce serum hormone levels, promote uterine leiomyoma volume reduction, reduce adverse drug reactions, The application value is remarkable.

Keywords

Uterine Leiomyoma, Serum Hormone, Mifepristone, Low Dose

Cite This Paper

Diancui Zhang, Peipei Sun, Tongzhen Zhao. Effect of Mifepristone in the Treatment of Uterine Leiomyoma. International Journal of Frontiers in Medicine (2021), Vol. 3, Issue 2: 5-8. https://doi.org/10.25236/IJFM.2021.030202.

References

[1] Zhang Dinghong, Wang Hongli. Comparison of clinical efficacy of different doses of mifepristone in the treatment of uterine leiomyoma [J]. Chinese Journal of Family Planning 28(11):1821-1823.

[2] Bai Xue, Zhang Jinzhi, Zhao Liwu, Liu Yan. Efficacy and safety of different doses of mifepristone in the treatment of patients with functional uterine bleeding during menopause [J].]; and China Maternal and Child Health Care, 2019, 34(21):4978-4980.

[3] Ren Ping. Effect of mifepristone combined with myomectomy on the level of cytokines and sex hormones in patients with uterine leiomyoma [J].]; and Shanxi Medical Journal, 2019, 48(22):2741-2744.

[4] Lei Jinfeng. Comparative observation on the efficacy of different doses of mifepristone in patients with uterine leiomyoma and its effect on estrogen and progesterone levels [J].]; and Capital Food and Medicine, 2019, 26(22):77-78.

[5] Zhang Jian, Reina, Xue Xiuzhen. Effect of Guizhi Fuling Pill combined with mifepristone on clinical efficacy and serum sex hormone level in patients with uterine leiomyoma [J].]1 Exploration of Rational Drug Use in China ,2020,17(11):39-42.

[6] Zhang Lizhen. Clinical efficacy and safety of Guizhi Fuling capsule combined with mifepristone in the treatment of uterine leiomyoma [J].]1 Capital Food and Medicine 27(03):102.

[7] Gao Qiong. Clinical Observation on Menopause Induced by Different Dosage of Mifepristone in Perimenopausal Uterine Myoma [J]. Chinese and Foreign Women's Health Research ,2020(01):49-50.

[8] Feng Yuanyuan, Zhao Zixiong. Clinical efficacy of laparoscopic surgery combined with low dose mifepristone in the treatment of endometriosis with infertility [J].].1 Exploration of rational Drug Use in China ,2020,17(02):48-53.

[9] Arora D,Chawla Jaya,Kochar S P S,Sharma J C.A randomized control trial to assess efficacy of Mifepristone in medical management of uterine fibroid.[J]. Medical journal,Armed Forces India, 2017,73(3).

[10] Liu Chongdong, Lu Qi, Qu Hong, Geng Li, Bian Meilu, Huang Minli, Wang Huilan, Zhang Youzhong, Wen Zeqing, Zheng Shurong, Zhang Zhenyu.Different dosages of mifepristone versus enantone to treat uterine fibroids:A multicenter randomized controlled trial.[J]. Medicine, 2017, 96(7).